THERAPY WITH NUCLEOSIDE ANALOGUES FOR HEPATITIS B VIRUS INFECTION
- 1 May 1999
- journal article
- Published by Elsevier in Clinics in Liver Disease
- Vol. 3 (2) , 349-361
- https://doi.org/10.1016/s1089-3261(05)70072-6
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Lamivudine and intron a combination treatment in patients with chronic hepatitis B infectionJournal of Hepatology, 1998
- Quantitative hepatitis B virus DNA assessment by the limiting‐dilution polymerase chain reaction in chronic hepatitis B patients: evidence of continuing viral suppression with longer duration and higher dose of lamivudine therapyJournal of Viral Hepatitis, 1998
- Treatment of fibrosing cholestatic hepatitis with lamivudineGastroenterology, 1998
- Identification and characterization of mutations in hepatitis B virus resistant to lamivudineHepatology, 1998
- Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapyHepatology, 1998
- Lamivudine treatment for one year in previously untreated U.S. hepatitis B patients: histologic improvement and hepatitis be-antigen (HBeAg) seroconversionGastroenterology, 1998
- Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantationJournal of Hepatology, 1997
- Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosisThe Lancet, 1996
- A Preliminary Trial of Lamivudine for Chronic Hepatitis B InfectionNew England Journal of Medicine, 1995
- Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patientsThe Lancet, 1995